Literature DB >> 19952116

Minimal-length short hairpin RNAs: the relationship of structure and RNAi activity.

Qing Ge1, Heini Ilves, Anne Dallas, Pavan Kumar, Joshua Shorenstein, Sergei A Kazakov, Brian H Johnston.   

Abstract

Small hairpin RNAs (shRNAs) are widely used in RNAi studies and typically consist of a stem of 19-29 base pairs (bp), a loop of at least 4 nucleotides (nt), and a dinucleotide overhang at the 3' end. Compared with shRNAs with 21-29 bp stems, we have found that shRNAs with 19-bp or shorter stems (sshRNAs) possess some unique structure-activity features that depend on whether the antisense strand is positioned 5' or 3' to the loop (L- or R-type sshRNAs, respectively). L sshRNAs can have IC(50)s in the very low picomolar range, and sshRNAs with nominal loop sizes of 1 or 4 nt were at least as active as those with longer loops. L sshRNAs remained highly potent even when the 3' end of the antisense strand was directly linked with the 5' end of the sense strand. In this case, the sense strand can be shorter than the antisense strand, and the loop can be formed entirely by the 3' end of the antisense strand. Monomer sshRNAs are not processed by recombinant Dicers in vitro. Although they can form dimers that are sometimes Dicer substrates, their RNAi activity is not dependent on the formation of such structures. Our findings have implications for the mechanism of action of sshRNAs, and the ability to design highly potent shRNAs with minimal length is encouraging for the prospects of the therapeutic use of direct-delivered shRNAs.

Mesh:

Substances:

Year:  2009        PMID: 19952116      PMCID: PMC2802021          DOI: 10.1261/rna.1894510

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  46 in total

Review 1.  Illuminating the silence: understanding the structure and function of small RNAs.

Authors:  Tariq M Rana
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

Review 2.  shRNA libraries and their use in cancer genetics.

Authors:  René Bernards; Thijn R Brummelkamp; Roderick L Beijersbergen
Journal:  Nat Methods       Date:  2006-09       Impact factor: 28.547

3.  Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.

Authors:  Mohammed Amarzguioui; Patric Lundberg; Edouard Cantin; James Hagstrom; Mark A Behlke; John J Rossi
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways.

Authors:  Dirk Grimm; Konrad L Streetz; Catherine L Jopling; Theresa A Storm; Kusum Pandey; Corrine R Davis; Patricia Marion; Felix Salazar; Mark A Kay
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

5.  Defining the optimal parameters for hairpin-based knockdown constructs.

Authors:  Leiming Li; Xiaoyu Lin; Anastasia Khvorova; Stephen W Fesik; Yu Shen
Journal:  RNA       Date:  2007-08-13       Impact factor: 4.942

6.  Inhibition of hepatitis C IRES-mediated gene expression by small hairpin RNAs in human hepatocytes and mice.

Authors:  Heini Ilves; Roger L Kaspar; Qian Wang; Attila A Seyhan; Alexander V Vlassov; Christopher H Contag; Devin Leake; Brian H Johnston
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

7.  RNA interference from multimeric shRNAs generated by rolling circle transcription.

Authors:  Attila A Seyhan; Alexander V Vlassov; Brian H Johnston
Journal:  Oligonucleotides       Date:  2006

8.  RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.

Authors:  Haibin Xia; Qinwen Mao; Steven L Eliason; Scott Q Harper; Inês H Martins; Harry T Orr; Henry L Paulson; Linda Yang; Robert M Kotin; Beverly L Davidson
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

9.  shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA.

Authors:  Alexander V Vlassov; Brent Korba; Kristine Farrar; Sampa Mukerjee; Attila A Seyhan; Heini Ilves; Roger L Kaspar; Devin Leake; Sergei A Kazakov; Brian H Johnston
Journal:  Oligonucleotides       Date:  2007

10.  Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155.

Authors:  Kwan-Ho Chung; Christopher C Hart; Sarmad Al-Bassam; Adam Avery; Jennifer Taylor; Paresh D Patel; Anne B Vojtek; David L Turner
Journal:  Nucleic Acids Res       Date:  2006-04-13       Impact factor: 16.971

View more
  36 in total

Review 1.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

2.  Toward optimization of AgoshRNA molecules that use a non-canonical RNAi pathway: variations in the top and bottom base pairs.

Authors:  Elena Herrera-Carrillo; Alex Harwig; Ben Berkhout
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

3.  Development of Novel Small Hairpin RNAs That do not Require Processing by Dicer or AGO2.

Authors:  Shin-Ichiro Ohno; Karen Itano; Yuichirou Harada; Koutaro Asada; Keiki Oikawa; Mikie Kashiwazako; Hikaru Okuyama; Katsuyoshi Kumagai; Masakatsu Takanashi; Katsuko Sudo; Norihiko Ikeda; Masahiko Kuroda
Journal:  Mol Ther       Date:  2016-04-25       Impact factor: 11.454

Review 4.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

5.  Formulated minimal-length synthetic small hairpin RNAs are potent inhibitors of hepatitis C virus in mice with humanized livers.

Authors:  Han Ma; Anne Dallas; Heini Ilves; Joshua Shorenstein; Ian MacLachlan; Klaus Klumpp; Brian H Johnston
Journal:  Gastroenterology       Date:  2013-09-27       Impact factor: 22.682

6.  Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers.

Authors:  Jonathan C Hagopian; Alexander S Hamil; Arjen van den Berg; Bryan R Meade; Akiko Eguchi; Caroline Palm-Apergi; Steven F Dowdy
Journal:  Nucleic Acid Ther       Date:  2017-09-21       Impact factor: 5.486

7.  Silencing of HIV-1 by AgoshRNA molecules.

Authors:  E Herrera-Carrillo; A Harwig; B Berkhout
Journal:  Gene Ther       Date:  2017-05-29       Impact factor: 5.250

8.  Effects of chemical modification on the potency, serum stability, and immunostimulatory properties of short shRNAs.

Authors:  Qing Ge; Anne Dallas; Heini Ilves; Joshua Shorenstein; Mark A Behlke; Brian H Johnston
Journal:  RNA       Date:  2009-11-30       Impact factor: 4.942

9.  Inhibition of hepatitis C virus in chimeric mice by short synthetic hairpin RNAs: sequence analysis of surviving virus shows added selective pressure of combination therapy.

Authors:  Anne Dallas; Heini Ilves; Han Ma; Daniel J Chin; Ian Maclachlan; Klaus Klumpp; Brian H Johnston
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

10.  Acceleration of Diabetic Wound Healing with PHD2- and miR-210-Targeting Oligonucleotides.

Authors:  Anne Dallas; Artem Trotsyuk; Heini Ilves; Clark A Bonham; Melanie Rodrigues; Karl Engel; Janos A Barrera; Nina Kosaric; Zachary A Stern-Buchbinder; Aleksandr White; Kenneth J Mandell; Paula T Hammond; Jonathan Mansbridge; Sumedha Jayasena; Geoffrey C Gurtner; Brian H Johnston
Journal:  Tissue Eng Part A       Date:  2018-06-29       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.